Inclusion and Exclusion Criteria
gastroesophageal junction cancers, gastric adenocarcinoma
GASTROESOPHAGEAL JUNCTION CANCER, GASTRIC ADENOCARCINOMA, ADVERSE REACTION, ONCOLOGY, GASTRIC CANCER
Adult patients with histologically diagnosed resectable gastric adenocarcinoma who were candidate to curative-intent laparoscopic distal gastrectomy were eligible for the study. Inclusion criteria were (1) cT1b-T4, cN0-N+, M0 preoperative staging; (2) performance status 0–1 per the Eastern Cooperative Oncology Group (ECOG) criteria; (3) age 18 to 80 years. Exclusion criteria were (1) previous gastric resection, or endoscopic submucosal resection of early gastric cancer; (2) presence of lymph nodes > 3 cm at preoperative staging; (3) indication to total or proximal gastrectomy, including gastroesophageal junction cancers; (4) previous adverse reaction to ICG injection; (5) pregnant or lactating patients; (6) patients with absolute contraindications to surgery.